Lobbying Activity Report

332-34022

Designated Filer name: Michael Bailey
Client: Boehringer Ingelheim (Canada) Ltd.
Associated registration: 1054-332-6
Lobbying Activity date: 2024-03-12
Arranged a meeting: Yes
Posted date: 2024-04-11

Senior Public Office Holders who were lobbied in this activity: Tijana Fazlagic, Executive Director
Therapeutic Assessment &Access Branch, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Had a discussion around how BC PharmaCare will possibly interact with the proposed National PharmaCare program Footnote1
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Health, Information Technology Footnote1
 
  1. Footnote1  Indicates new information that was added through a Lobbying Activity Report.
Date Modified: